3,11-Diketofusidic Acid

IMPURITIES

Product Details

CAT No.# CS-T-53452
Category Impurities
CAS 3482-38-0
Molecular Weight 512.68
Molecular Formula C31H44O6
Stock Status: In-Stock
Purity: >98%
Solubility: DCM, Ethyl Acetate, Methanol
Appearance: Off-White Solid
Synonyms: 3,11-Dideoxy-3,11-dioxofusZ)-16β-Hydroxy-3,11-dioxo-29-Nor-8α,9β,13α,14β-dammara-17(20),24-dien-21(4α,8α,9β,13α,14β,16β,17Z)-16-(Acetyloxy)-3,11-dioxo-29-nordammara-17(20),24-dien-21-oic Acid;(Z)-6-methyl-2-((4S,8S,9R,10S,13R,14R,16S)-4,10,14-trimethyl-3,; 3,11-dioxo-Fusidic acid; 3,11-Dideoxy-3,11-dioxofusidic acid; 3,11-Diketofusidic acid
Application Notes: 3,11-Diketofusidic Acid is an intermediate in the synthesis of Fusidic Acid metabolites.
References: Bodley, J.W., et al.: Biochem. BIophy. Res. Commun., 46, 871 (1972);
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
CCC(O[C@H]1C[C@@]2([C@H]3CCC4[C@@H](C(CC[C@@]4([C@@H]3C(C[C@H]2/C1=C(C(O)=O)\CC/C=C(C)/C)=O)C)=O)C)C)=O



This page contains information about 3,11-Diketofusidic Acid Cas 3482-38-0 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."